Cases of leishmaniasis in SP spread, study indicates
Have you ever heard of leishmaniasis? We have spoken of it here in My Life for some time, reporting cases more and more frequent in the interior of São Paulo. But now, a study done in Unoeste mapped the extent and progress of these cases and found that they are closer to the city of São Paulo.
In 1999> , only two cities had reports of cases of visceral leishmaniasis. In 2017, this number rose to 97 municipalities, mainly in the northwest region of the state.
The idea of the study is to alert the public managers of São Paulo, since the disease is spreading rapidly and independent of the conditions of socioeconomic development
"The control is very difficult, it depends on the environment, the infected dogs, the diagnosis, the treatment of infected people and public actions on the control of urban and animal waste. mosquito-straw, which adapts very well in hot and humid summer regions, such as Pontal and other regions of Brazil where the disease is emerging, in areas of sawing and environmental degradation, "says researcher Dr.
How to get Leishmaniasis?
The disease is passed through the bite of the mosquito-straw or birigui when infected by the protozoan Le ishmania chagasi .
Today, the best way to prevent leishmaniasis is by controlling the mosquito and preventing dogs from being bitten by the mosquito as well.
Types of mosquitoes Leishmaniasis
Leishmaniasis that has spread to the state of São Paulo is the visceral, the most serious type, already attacks internal organs such as liver, spleen and bone marrow.
In addition there is cutaneous leishmaniasis, which is usually more common and causes skin sores.
No matter the sex, age, educational level or status of depression or mental illness "If people in the study had difficulty chewing, they had a higher chance of cognitive impairment. The research is detailed in the article "Ability to Chew and Loss of Tooth: Association with Cognitive Impairment in the Population of the Elderly Study?
Saxenda is an injectable drug used for the treatment of obesity, which was approved by the National Agency for Sanitary Surveillance (ANVISA) at the end of February 2016. It has been drawing attention since 2014 when it was approved by the Food and Drug Administration (FDA), the United States Food and Drug Regulatory Body, and the European Medicines Commission in 2015.